Skip to content
healthcare.dev
Get a free key

KEYTRUDA QLEX

NDC 0006-3083, pembrolizumab and berahyaluronidase alfa-pmph, injection, solution, from Merck Sharp & Dohme LLC.

Product NDC
0006-3083
Status
Listed
Labeler
Merck Sharp & Dohme LLC
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761467
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0006-3083 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PEMBROLIZUMAB165 mg/mL
  • BERAHYALURONIDASE ALFA2000 U/mL

Pharmacologic classes

Endoglycosidase [EPC]; Glycoside Hydrolases [CS]; Programmed Death Receptor-1 Blocking Antibody [EPC]; Programmed Death Receptor-1-directed Antibody Interactions [MoA]

Package NDCNDC-11Package
0006-3083-01000063083011 VIAL in 1 CARTON (0006-3083-01) / 2.4 mL in 1 VIAL (0006-3083-99)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/097d166f-b73b-41d3-9b37-7653cd2a0c41

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0006-3083

Use it

Look up 0006-3083 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0006-3083 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0006-3083. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.